TPIDB > 臨床試驗主持人
臨床試驗主持人
更新時間：2023-09-19
林永昌Lin, Yung-Chang
- 計畫主持人
- 執行臨床試驗年資 17 年 9 個月
發表文獻
20筆
11
Kang, C.W., Dutta A., Chang L.Y., Mahalingam J., Lin Y.C., Chiang J.M., Hsu C.Y., Huang C.T., Su W.T., Chu Y.Y. and Lin C.Y. (2015). "Apoptosis of tumor infiltrating effector TIM-3+CD8+ T cells in colon cancer." Sci Rep 5: 15659.
12
Chang L-Y, Lin Y-C, Chiang J-M, Mahalingam J, Su S-H, et al. (2015) Blockade of TNF-α signaling benefits cancer therapy by suppressing effector regulatory T cell expansion. OncoImmunology 4: e1040215.
13
Huang CY, Lu CH, Yang CK, Hsu HC, Kuo YC, Huang WK, Chen JS, Lin YC, Chia-Yen H, Shen WC, Chang PH, Yeh KY, Hung YS, Chou WC. A Simple Risk Model to Predict Survival in Patients With Carcinoma of Unknown Primary Origin. Medicine (Baltimore). 2015 Nov;94(47):e2135. doi: 10.1097/MD.0000000000002135.
14
Chen ML, Liu LN, Miaskowski C, Chen SC, Lin YC, et al. (2015) Presurgical symptom profiles predict quality of life 2 years after surgery in women with breast cancer. Support Care Cancer. May 27.
15
Wu, C. E., S. C. Chen, H. K. Chang, Y. F. Lo, S. Hsueh and Y. C. Lin (2015). "Identification of patients with hormone receptor-positive breast cancer who need adjuvant tamoxifen therapy for more than 5 years." J Formos Med Assoc. pii: S0929-6646(15)00131-X. doi: 10.1016/j.jfma.2015.03.003. (correspondence)
16
Rau, K. M., Y. C. Lin, Y. Y. Chen, J. S. Chen, K. D. Lee, C. H. Wang and H. K. Chang (2015). "Pegylated liposomal doxorubicin (Lipo-Dox(R)) combined with cyclophosphamide and 5-fluorouracil is effective and safe as salvage chemotherapy in taxane-treated metastatic breast cancer: an open-label, multi-center, non-comparative phase II study." BMC Cancer 15: 423.
17
Chou, W. C., K. Y. Yeh, M. T. Peng, J. S. Chen, H. M. Wang, Y. C. Lin, C. T. Liu, P. H. Chang, C. H. Wang, P. T. Chen, Y. S. Hung, C. H. Lu and S. H. Li (2015). "Development and Validation of a Prognostic Score to Predict Survival in Adult Patients With Solid Tumors and Bone Marrow Metastases." Medicine (Baltimore) 94(23): e966.
18
Chou, W. C., F. Wang, Y. F. Cheng, M. F. Chen, C. H. Lu, C. H. Wang, Y. C. Lin and T. S. Yeh (2015). "A simple risk stratification model that predicts 1-year postoperative mortality rate in patients with solid-organ cancer." Cancer Med. Aug 26. doi: 10.1002/cam4.518. (co-correspondence)
19
Chiang, T. Y., C. H. Wang, Y. F. Lin, S. L. Chou, C. T. Wang, H. T. Juang, Y. C. Lin and M. H. Lin (2015). "Factors related to treatment refusal in Taiwanese cancer patients." Asian Pac J Cancer Prev 16(8): 3153-3157.
20
Dutta, A., C. T. Huang, T. C. Chen, C. Y. Lin, C. H. Chiu, Y. C. Lin, C. S. Chang and Y. C. He (2015). "IL-10 inhibits neuraminidase-activated TGF-beta and facilitates Th1 phenotype during early phase of infection." Nat Commun 6: 6374.
1
2
